Task: Answer the MCQ question.
Question: Which drug exhibits a -2.882% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a: N#Cc1c(NCCO)ccc([N+](=O)[O-])c1NCCO
b: C/C(CCc1ccccc1)=N\NC(=S)NCCc1ccccc1
Answer: a. N#Cc1c(NCCO)ccc([N+](=O)[O-])c1NCCO
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
N#Cc1c(NCCO)ccc([N+](=O)[O-])c1NCCO
N#Cc1c(NCCO)ccc([N+](=O)[O-])c1NCCO
2,6-bis(2-hydroxyethylamino)-3-nitrobenzonitrile